+ All Categories
Home > Documents > OSCE heamatology

OSCE heamatology

Date post: 05-Apr-2018
Category:
Upload: bnive
View: 239 times
Download: 0 times
Share this document with a friend

of 32

Transcript
  • 7/31/2019 OSCE heamatology

    1/32

  • 7/31/2019 OSCE heamatology

    2/32

    Station 1

    This is the

    peripheral smear of

    a 12 year old

    female child who

    presented with

    pancytopenia. Also

    shown is the bonemarrow picture of

    this child. Kindly

    give the diagnosis

  • 7/31/2019 OSCE heamatology

    3/32

    Answer Station 1

    Megaloblastic anemia

  • 7/31/2019 OSCE heamatology

    4/32

    Station 2

    What ancillary tests will you do to clinch

    the diagnosis? Give any two.

  • 7/31/2019 OSCE heamatology

    5/32

    Answers Station 2

    LDH

    S. Bilirubin

    Vit B12 level S. Folic Acid levels

  • 7/31/2019 OSCE heamatology

    6/32

    Station 3

    What are the recommended dosages for

    the treatment of Vitamin B 12 and Folic

    Acid deficiency

  • 7/31/2019 OSCE heamatology

    7/32

  • 7/31/2019 OSCE heamatology

    8/32

    Station 4

    This is the peripheral

    smear of a patient who

    came with purpuric spots

    and hemoglobin of 10,

    mildly hypochromic

    microcytic picture.

    Identify the cell shown

  • 7/31/2019 OSCE heamatology

    9/32

    Answer Station 4

    Giant Platelets

  • 7/31/2019 OSCE heamatology

    10/32

    Station 5

    This is the peripheral smear of a 4 year old child

    who presented with a Hb of 10gm/dL, TLC 9000,

    Platelet 30,000 and no organomegaly or

    lymphadenopathy. The child had purpura but nosignificant bleed. Was stable. Parents are well

    educated and live in Delhi.

    What will be the drug to treat this patient?

    Will you do a bone marrow in this patient?

  • 7/31/2019 OSCE heamatology

    11/32

    Answers Station 5

    No treatment is required. Just observation

    No need for bone marrow

  • 7/31/2019 OSCE heamatology

    12/32

    Station 6

    Kindly counsel the parents of this child

  • 7/31/2019 OSCE heamatology

    13/32

    Answers Station 6

    Introduces himself and tries to make the parents

    comfortable.

    Talks about the disease ITP

    Talks about the possibility of any other disease

    Talks about the need for injury prevention

    Tells about the warning signs when they have to

    report to the hospital Talks about the self limiting nature of the

    disease

  • 7/31/2019 OSCE heamatology

    14/32

    Station 7

    Hb 10

    MCV 58 MCH 23

    MCHC 32

    RBC Count 5.4 RDW 13.5

    P/Smear As shown

  • 7/31/2019 OSCE heamatology

    15/32

    Questions Station 7

    Kindly comment on the peripheral smear

    and identify the cell shown.

    Give your probable diagnosis in the

    patient with the above indices and

    P/Smear

  • 7/31/2019 OSCE heamatology

    16/32

    ANSWER 7

    :MICROCYTIC HYPOCHROMICANAEMIA WITH TARGET CELL

    : BETA THALASEMIA TRAIT

  • 7/31/2019 OSCE heamatology

    17/32

    Station 8

    1. Identify the spot (Arrow)

    2. Name the agents

    used to stain this cell

  • 7/31/2019 OSCE heamatology

    18/32

    Answers Station 8

    Myeloblast with 3 prominent nuclei

    Stains- Myeloperoxidase, Non specific

    esterase and Sudan black

  • 7/31/2019 OSCE heamatology

    19/32

    Station 10

    2 yr old child was evaluated foranemia and found to have areticulocyte count of 20% and a

    PCV of 25%. Calculate the Reticulocyte

    production index takingmaturation time as 2 days andassuming a normal PCV of 0.45

    What does this signify? (In termsof production rate)

  • 7/31/2019 OSCE heamatology

    20/32

    Answers Station 10

    RPI = Reticulocyte % x Observed PCV(0.25)

    Maturation time x Normal PCV (0.45)

    It comes = 5.5

    It signifies that production has increased to 5.5 times

  • 7/31/2019 OSCE heamatology

    21/32

    Station 11

    18 month old child

    with pallor and

    cutaneous markers

    at the back with anabnormal skeletal

    profile. P/S was

    consistent with

    macrocytic anemiaand pancytopenia.

    http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom?picture=%5Cwebsites%5Cemedicine%5Cped%5Cimages%5Clarge%5C19931993PED3022-03.JPG&fzi=1
  • 7/31/2019 OSCE heamatology

    22/32

    Questions Station 11

    What is the most probable diagnosis?

    Name the cutaneous marker.

    What malignancies are expected in thispatient?

  • 7/31/2019 OSCE heamatology

    23/32

    Answers Station 11

    Fanconi anemia

    Caf au lait spot

    Acute leukemia

  • 7/31/2019 OSCE heamatology

    24/32

    Station 12

    Identify the spot

    with arrow?

    Define it

  • 7/31/2019 OSCE heamatology

    25/32

    Answer Station 12

    Band cell

    Its a cell of neutrophil (Leukocyte)

    series in which the nucleus appears to

    be folded and the joining isthmus of the

    two lobules is > 1/3rd of the maximum

    width of the largest lobule

  • 7/31/2019 OSCE heamatology

    26/32

    Station 13

    Give the full form of SQUID and what it

    is best used for?

    Give the full form of NESTROF and

    what it is used for?

    What is the principle used in NESTROF

    test?

  • 7/31/2019 OSCE heamatology

    27/32

    Answer Station 13

    SQUID- Super-conducting QuantumInterference Device & Provides the mostaccurate and best-validated non-invasivemethod for measuring liver iron

    NESTROF- Naked Eye Single Tube Red CellOsmotic Fragility Test and it is usefull inscreening for beta-thalassaemia and some ofthe common haemoglobinopathies

    The principle of NESTROF is based on thelimit of hypotonicity which the red cell canwithstand.

  • 7/31/2019 OSCE heamatology

    28/32

    THANK YOU!!!

  • 7/31/2019 OSCE heamatology

    29/32

    This child has a

    history of polyuria,frequent otitis mediaand bone pains

    What is the mostprobable diagnosis?

    Name of theepidermis layerwhere this cell isfound?

    What does it

    contain?

  • 7/31/2019 OSCE heamatology

    30/32

  • 7/31/2019 OSCE heamatology

    31/32

    Station 15

    Identify the spot

    in the marrow

    What is the

    treatment for

    this? Name two

    drugs

  • 7/31/2019 OSCE heamatology

    32/32

    Answer Station 15

    LD Body

    Amphotericin B & Sodium Stibogluconate,

    Multifosein


Recommended